Chief Medical Officer

The University of New Mexico Cancer Center (UNMCC) and the Department of Internal Medicine, Division of Hematology/Oncology invites applicants with a record of directly relevant accomplishments to apply for the Chief Medical Officer (CMO) at the UNMCC. This person is responsible for the direct oversight of clinical operations and is accountable for the delivery of high quality, cost effective patient care at the UNMHCC. This person will have a direct reporting relationship to the Director of the UNMCC and to the Chief Executive Officer of UNM Hospital (UNMH) and the University Health Science Center’s Chief Medical Officer. The CMO works with the Division Chiefs of the various Departments who have physicians at the UNMHCC to ensure coverage of clinics and Quality of Care. The remaining duties of the CMO comprise of administrative oversight of the clinical enterprise, and responsibility for all domains of quality and safety. Faculty rank and appointment will be commensurate with accomplishments.
Administrative oversight entails the clinical enterprise and various components. The successful applicant oversees the Medical Directors at the UNMCC, Lovelace Hospital In-Patient wards, University Hospital and Memorial Medical Center, Las Cruces; chairs and directs the Clinical Operations Committee; has a direct reporting relationship with the Radiation Oncology Director, Oncology Pharmacy Services Direct, Clinical Operations Direct; works with Patient Access and Information Technology to ensure quality and safety of the global operational functionality; and provides integration of the oncology associated operations between UNMCC and UNMH.

The UNM Cancer Center (cancer.unm.edu) is one of the nation’s 66 premier National Cancer Institute-designated Cancer Centers and the Official Cancer Center of New Mexico. With 85 associated physicians and 127 scientists recruited from leading institutions nationwide and supported by $70 million in annual research funding, the Center has undergone remarkable growth in the past 10 years and is home to the region’s most experienced team of cancer specialists. In 2011, the Center cared for 16,000 patients in more than 175,000 ambulatory clinic visits in a newly constructed state of the art cancer treatment facility. The Center’s statewide cancer clinical trials network accrues 20% of its patients annually to therapeutic clinical trials. The Center has significant capabilities in cancer drug discovery and novel therapeutic delivery, housing one of the nation’s 9 NIH Roadmap-funded Centers for Molecular Discovery and High Throughput Target Screening (nmmlsc.health.unm.edu), one of 10 NIH-funded Centers for Systems Biology with advanced with imaging capabilities (stmc.health.unm.edu), and an NCI Nanotechnology Alliance-funded program developing novel nanocarriers for targeted delivery of cancer therapeutics and imaging agents.

Direct Employer

1 University of New Mexico
MSC 07-4025
Albuquerque, NM 87131

12/18/2013

1/17/2014